Anti-MET7A/ METTL7A/ AAM-B functional antibody

Anti-MET7A/ METTL7A/ AAM-B functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to METTL7A/METTL7A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0339-Ab-1/ GM-Tg-hg-SE0339-Ab-2Anti-Human METTL7A monoclonal antibodyHuman
GM-Tg-rg-SE0339-Ab-1/ GM-Tg-rg-SE0339-Ab-2Anti-Rat METTL7A monoclonal antibodyRat
GM-Tg-mg-SE0339-Ab-1/ GM-Tg-mg-SE0339-Ab-2Anti-Mouse METTL7A monoclonal antibodyMouse
GM-Tg-cynog-SE0339-Ab-1/ GM-Tg-cynog-SE0339-Ab-2Anti-Cynomolgus/ Rhesus macaque METTL7A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0339-Ab-1/ GM-Tg-felg-SE0339-Ab-2Anti-Feline METTL7A monoclonal antibodyFeline
GM-Tg-cang-SE0339-Ab-1/ GM-Tg-cang-SE0339-Ab-2Anti-Canine METTL7A monoclonal antibodyCanine
GM-Tg-bovg-SE0339-Ab-1/ GM-Tg-bovg-SE0339-Ab-2Anti-Bovine METTL7A monoclonal antibodyBovine
GM-Tg-equg-SE0339-Ab-1/ GM-Tg-equg-SE0339-Ab-2Anti-Equine METTL7A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0339-Ab-1/ GM-Tg-hg-SE0339-Ab-2; GM-Tg-rg-SE0339-Ab-1/ GM-Tg-rg-SE0339-Ab-2;
GM-Tg-mg-SE0339-Ab-1/ GM-Tg-mg-SE0339-Ab-2; GM-Tg-cynog-SE0339-Ab-1/ GM-Tg-cynog-SE0339-Ab-2;
GM-Tg-felg-SE0339-Ab-1/ GM-Tg-felg-SE0339-Ab-2; GM-Tg-cang-SE0339-Ab-1/ GM-Tg-cang-SE0339-Ab-2;
GM-Tg-bovg-SE0339-Ab-1/ GM-Tg-bovg-SE0339-Ab-2; GM-Tg-equg-SE0339-Ab-1/ GM-Tg-equg-SE0339-Ab-2
Products NameAnti-METTL7A monoclonal antibody
Formatmab
Target NameMETTL7A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-METTL7A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0339-Ag-1Recombinant multi-species MET7A/ METTL7A/ AAM-B protein
    ORF Viral VectorvGMLP003064human METTL7A Lentivirus particle
    ORF Viral VectorpGMLP003064human METTL7A Lentivirus plasmid
    ORF Viral VectorpGMLPm000894mouse Mettl7a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm000894mouse Mettl7a1 Lentivirus particle


    Target information

    Target IDGM-SE0339
    Target NameMETTL7A
    Gene ID25840,315306,693894,100685262,111556213,613844,100060363
    Gene Symbol and SynonymsAAM-B,AAMB,METTL7A,RGD1308407,™T1A
    Uniprot AccessionQ9H8H3
    Uniprot Entry NameMET7A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185432
    Target ClassificationN/A

    The target: METTL7A, gene name: METTL7A, also named as AAM-B. Predicted to enable methyltransferase activity. Predicted to be involved in methylation. Located in lipid droplet. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.